TAZ Inhibits Osteoclastogenesis by Attenuating TAK1/NF-κB Signaling

The authors demonstrated that global knockout and osteoclast-specific knockout of transcriptional coactivator with PDZ-binding motif (TAZ) led to a low-bone mass phenotype due to elevated osteoclast formation, which was further evidenced by in vitro osteoclast formation assays.